ATE424837T1 - Verwendung von lanthan bei der behandlung von knochenerkrankungen - Google Patents
Verwendung von lanthan bei der behandlung von knochenerkrankungenInfo
- Publication number
- ATE424837T1 ATE424837T1 AT01940848T AT01940848T ATE424837T1 AT E424837 T1 ATE424837 T1 AT E424837T1 AT 01940848 T AT01940848 T AT 01940848T AT 01940848 T AT01940848 T AT 01940848T AT E424837 T1 ATE424837 T1 AT E424837T1
- Authority
- AT
- Austria
- Prior art keywords
- lanthan
- gum
- treatment
- bone diseases
- bone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/244—Lanthanides; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/06—Chelate
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0015745.3A GB0015745D0 (en) | 2000-06-27 | 2000-06-27 | Treatment of bone diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE424837T1 true ATE424837T1 (de) | 2009-03-15 |
Family
ID=9894512
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01940848T ATE424837T1 (de) | 2000-06-27 | 2001-06-26 | Verwendung von lanthan bei der behandlung von knochenerkrankungen |
AT0075606U AT9687U1 (de) | 2000-06-27 | 2006-10-19 | Verwendung von lanthan bei der behandlung von knochenerkrankungen |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT0075606U AT9687U1 (de) | 2000-06-27 | 2006-10-19 | Verwendung von lanthan bei der behandlung von knochenerkrankungen |
Country Status (11)
Country | Link |
---|---|
US (2) | US7078059B2 (de) |
EP (2) | EP1294384B1 (de) |
JP (1) | JP2004501198A (de) |
AT (2) | ATE424837T1 (de) |
AU (2) | AU2001274341B2 (de) |
CA (1) | CA2415228C (de) |
DE (1) | DE60137929D1 (de) |
DK (1) | DK200600250U4 (de) |
FI (1) | FI7569U1 (de) |
GB (1) | GB0015745D0 (de) |
WO (1) | WO2002000227A2 (de) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100015246A1 (en) * | 2000-06-27 | 2010-01-21 | Shire International Licensing B.V. | Combination of a lanthanum compound and bone enhancing agent for the treatment of bone diseases |
US7858602B2 (en) * | 2000-10-16 | 2010-12-28 | Rodriguez Victorio C | Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging disorders due to oxidative stress and as growth factors of stem cells |
AU2003229437A1 (en) * | 2002-05-08 | 2003-11-11 | Shire Holding Ag | Use of lanthanum for the treatment of hypercalcemia and bone metastasis |
US20060083791A1 (en) | 2002-05-24 | 2006-04-20 | Moerck Rudi E | Rare earth metal compounds methods of making, and methods of using the same |
US20040161474A1 (en) * | 2002-05-24 | 2004-08-19 | Moerck Rudi E. | Rare earth metal compounds methods of making, and methods of using the same |
EP1647524A3 (de) * | 2002-08-14 | 2006-09-13 | Altair Nanomaterials Inc. | Seltenerdmetallzusammensetzungen, Verfahren zu deren Herstellung und Verwendung |
AU2003282867A1 (en) * | 2002-10-22 | 2004-05-13 | Genzyme Corporation | Amine polymers for promoting bone formation |
SI2266584T1 (sl) * | 2003-05-07 | 2012-12-31 | Osteologix A/S, Symbion | Sestavek s stroncijem in vitaminom D za profilakso in/ali zdravljenje patologij hrustanca in/ali kosti |
PT1534305E (pt) * | 2003-05-07 | 2007-02-28 | Osteologix As | Tratamento de afecções cartilagineas / osseas com sais de estroncio hidrosoluveis |
WO2004098617A2 (en) * | 2003-05-07 | 2004-11-18 | Osteologix A/S | Controlled release composition containing a strontium salt |
US7381428B2 (en) | 2003-08-26 | 2008-06-03 | Shire International Licensing B.V. | Stabilized lanthanum carbonate compositions |
SI2172205T1 (sl) * | 2003-08-26 | 2014-10-30 | Shire Biopharmaceuticals Holdings Ireland Limited | Farmacevtska formulacija obsegajoča lantanove spojine |
MX2007001114A (es) * | 2004-07-27 | 2007-07-11 | Shire Pharmaceuticals Inc | Metodo para tratar hiperfosfatemia usando hidroxicarbonato de lantano. |
CA2583548A1 (en) * | 2004-10-15 | 2006-04-27 | Altairnano, Inc. | Phosphate binder with reduced pill burden |
EP1698233A1 (de) * | 2005-03-01 | 2006-09-06 | Bayer HealthCare AG | Verringerung der Aufnahmefähigkeit von Phosphor in der Tierernährung |
WO2007022445A2 (en) * | 2005-08-17 | 2007-02-22 | Altairnano, Inc. | Treatment of chronic renal failure and other conditions in domestic animals: compositions and methods |
US20110046059A1 (en) * | 2005-09-06 | 2011-02-24 | Zelos Therapeutics, Inc. | Pharmaceutically acceptable formulations/compositions for peptidyl drugs |
AU2006343306A1 (en) * | 2005-09-06 | 2007-11-15 | Zelos Therapeutics, Inc. | Parathyroid hormone analogues and methods of use |
US20070104799A1 (en) * | 2005-11-09 | 2007-05-10 | Shire International Licensing B.V. | Treatment of chronic kidney disease (CKD) subjects using lanthanum compounds |
US20070259052A1 (en) * | 2006-05-05 | 2007-11-08 | Shire International Licensing B.V. | Assay for lanthanum hydroxycarbonate |
CA2690848A1 (en) * | 2007-06-07 | 2008-12-11 | Jane E. Aubin | Estrogen receptor-related receptor gamma (erry) in bone and cartilage formation and methods and compositions relating to same |
GB0806801D0 (en) * | 2008-04-15 | 2008-05-14 | Immunodiagnostic Systems Ltd | Substrate |
CA3224506A1 (en) | 2010-05-12 | 2011-11-17 | Unicycive Therapeutics, Inc. | Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use |
US9261519B2 (en) | 2010-06-10 | 2016-02-16 | Arizona Board Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizona State University | Isotopic biomarkers for rapid assessment of bone mineral balance in biomedical applications |
KR20180079450A (ko) * | 2010-06-11 | 2018-07-10 | 몰리코프 미네랄스, 엘엘씨 | 폐수로부터 생리 활성 화합물의 개선 |
US20160220639A1 (en) * | 2013-09-11 | 2016-08-04 | New York University | Methods and compositions for treating bone diseases |
US9975787B2 (en) | 2014-03-07 | 2018-05-22 | Secure Natural Resources Llc | Removal of arsenic from aqueous streams with cerium (IV) oxide compositions |
EP2932974A1 (de) * | 2014-04-15 | 2015-10-21 | Chemische Fabrik Budenheim KG | Zusammensetzung zur Vorbeugung und Behandlung von Knochenerkrankungen |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2493704A1 (fr) * | 1980-11-07 | 1982-05-14 | Lemouel Jean | Composition pour la prophylaxie et les soins de la carie dentaire |
US5869473A (en) * | 1988-08-02 | 1999-02-09 | Bone Care International, Inc. | Method for treating and preventing hyperparathyroidism |
US5171583A (en) | 1988-10-21 | 1992-12-15 | The Regents Of The University Of California | Treatment of osteoporosis using potassium bicarbonate |
US5342604A (en) * | 1988-10-31 | 1994-08-30 | The Dow Chemical Company | Complexes possessing ortho ligating functionality |
US5696239A (en) | 1988-10-31 | 1997-12-09 | The Dow Chemical Company | Conjugates possessing ortho ligating functionality and complexes thereof |
GB9506126D0 (en) | 1995-03-25 | 1995-05-10 | Johnson Matthey Plc | Pharmaceutical composition and method |
US5902825A (en) * | 1997-01-07 | 1999-05-11 | Mitreoak, Ltd. | Composition and method for the palliation of pain associated with diseases of the bone and bone joints |
PT1334367E (pt) * | 2000-10-13 | 2006-10-31 | Abbott Lab | Metodo de determinacao da dose inicial de compostos de vitamina d |
US20040082588A1 (en) * | 2002-09-30 | 2004-04-29 | Schering Corporation | Methods for treating disorders of calcium homeostasis |
SI2172205T1 (sl) * | 2003-08-26 | 2014-10-30 | Shire Biopharmaceuticals Holdings Ireland Limited | Farmacevtska formulacija obsegajoča lantanove spojine |
-
2000
- 2000-06-27 GB GBGB0015745.3A patent/GB0015745D0/en not_active Ceased
-
2001
- 2001-06-26 AU AU2001274341A patent/AU2001274341B2/en not_active Ceased
- 2001-06-26 DE DE60137929T patent/DE60137929D1/de not_active Expired - Lifetime
- 2001-06-26 EP EP01940848A patent/EP1294384B1/de not_active Expired - Lifetime
- 2001-06-26 US US09/891,206 patent/US7078059B2/en not_active Expired - Fee Related
- 2001-06-26 CA CA2415228A patent/CA2415228C/en not_active Expired - Fee Related
- 2001-06-26 AU AU7434101A patent/AU7434101A/xx active Pending
- 2001-06-26 WO PCT/GB2001/002836 patent/WO2002000227A2/en active Application Filing
- 2001-06-26 JP JP2002505009A patent/JP2004501198A/ja active Pending
- 2001-06-26 AT AT01940848T patent/ATE424837T1/de not_active IP Right Cessation
- 2001-06-26 EP EP08164189A patent/EP2052725A2/de not_active Withdrawn
-
2006
- 2006-02-02 US US11/347,509 patent/US20070048390A1/en not_active Abandoned
- 2006-09-22 FI FI20060389U patent/FI7569U1/fi not_active IP Right Cessation
- 2006-09-26 DK DK200600250U patent/DK200600250U4/da not_active IP Right Cessation
- 2006-10-19 AT AT0075606U patent/AT9687U1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DK200600250U1 (da) | 2007-01-12 |
GB0015745D0 (en) | 2000-08-16 |
JP2004501198A (ja) | 2004-01-15 |
WO2002000227A8 (en) | 2004-04-15 |
WO2002000227A2 (en) | 2002-01-03 |
FI7569U1 (fi) | 2007-07-17 |
WO2002000227A3 (en) | 2002-08-29 |
EP1294384A2 (de) | 2003-03-26 |
DK200600250U4 (da) | 2008-09-12 |
CA2415228C (en) | 2011-09-06 |
FIU20060389U0 (fi) | 2006-09-22 |
AU7434101A (en) | 2002-01-08 |
US20020051822A1 (en) | 2002-05-02 |
EP2052725A2 (de) | 2009-04-29 |
AT9687U1 (de) | 2008-02-15 |
US20070048390A1 (en) | 2007-03-01 |
DE60137929D1 (de) | 2009-04-23 |
US7078059B2 (en) | 2006-07-18 |
EP1294384B1 (de) | 2009-03-11 |
AU2001274341B2 (en) | 2006-10-19 |
CA2415228A1 (en) | 2002-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE424837T1 (de) | Verwendung von lanthan bei der behandlung von knochenerkrankungen | |
DE60216275D1 (de) | Verwendung von mit azetidinon substituierten derivaten bei der behandlung der alzheimer-krankheit | |
ATE273954T1 (de) | Verbindungen zur anwendung bei der behandlung entzündlicher erkrankungen | |
DE60124302D1 (de) | Thiazolderivate zur behandlung von ppar-lierte krankheiten | |
ATE374204T1 (de) | Thienopyrimidinedione und deren verwendung in der behandlung von autoimmunerkrankungen | |
ATE417602T1 (de) | Mittel zur behandlung von erkrankungen der speiseröhre | |
DE69903543T2 (de) | Formulierungen zur behandlung von magen-speiseröhren reflux | |
DE60108080D1 (de) | Aminopyrazolderivate zur behandlung von übergewicht und anderen gesundheitsstörungen | |
DE50306850D1 (de) | Benzodiazepin-substituierte piperdine zur verwendung in der behandlung von cardiovaskulären erkrankungen | |
DE60023128D1 (de) | Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen | |
DE602004022061D1 (de) | Verwendung von modifizierten cyclosporinen zur behandlung von hcv-erkrankungen | |
DE69918687D1 (de) | 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen | |
DE60221569D1 (de) | Acrylsulfonamidderivate zur verwendung als ccr3-antagonisten bei der behandlung von inflammatorischen und immunologischen erkrankungen | |
DE50214540D1 (de) | Stanz bei der behandlung von wunden | |
DE60233265D1 (de) | 5-sulfanyl-4h-1,2,4-triazolderivate und deren verwendung zur behandlung von somatostatine vermittelten krankheiten | |
DE60023816D1 (de) | Verwendung von Lycopin in Zusammensetzungen zur Behandlung von Hautalterungs-Erscheinungen | |
DE60140516D1 (de) | Behandlung von fluorkohlenstoff- ausgangsmaterialien | |
DE60123238D1 (de) | Zusammensetzungen zur behandlung von autoimmunkrankheiten | |
DE69824576D1 (de) | Verwendung von tetrahydropyridinderivaten zur herstellung von arzneimitteln zur behandlung demyelinisierender erkrankungen | |
DE60136477D1 (de) | Retinoide zur behandlung von emphysem | |
DE60130661D1 (de) | Verwendung der 13-cis retinsäure zur behandlung von emphysemen | |
DE50013843D1 (de) | Arzneimittel zur behandlung von darmerkrankungen | |
DE60016047D1 (de) | Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten | |
DE69931487D1 (de) | Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation | |
DE60117122D1 (de) | Verwendung von mirtazapin zur behandlung von schlafstörungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |